Related references
Note: Only part of the references are listed.Cyclooxygenase-2 in oncogenesis
Maria Teresa Rizzo
CLINICA CHIMICA ACTA (2011)
Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
Claudia Bocca et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients
X. F. Ren et al.
ANAESTHESIA (2010)
GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells
Yufeng Miao et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67
Elin Richardsen et al.
CANCER EPIDEMIOLOGY (2010)
Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages
Patrice Forget et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)
Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E2 production using intravenous anesthetic propofol
Takefumi Inada et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
Rachel S. Midgley et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor
Ariella Glasner et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells
Evgeniy Eruslanov et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Giovanni Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
Craig A. Elmets et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE2 signalling in colorectal adenoma cells
A. Greenhough et al.
ONCOGENE (2010)
Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro
C. A. Deegan et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells
Takefumi Inada et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Propofol: A review of its non-anaesthetic effects
Ioanna Vasileiou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Propofol Suppresses Prostaglandin E2Production in Human Peripheral Monocytes
Tomoko Kambara et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice
Takefumi Inada et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis
Marganit Benish et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer
Shalini Jain et al.
CANCER RESEARCH (2008)
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
Mayumi Ono
CANCER SCIENCE (2008)
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration
Jui-Hung Yen et al.
BLOOD (2008)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Enhancement of antitumor immunity after propofol treatment in mice
Atsuko Kushida et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer
S Sharma et al.
CANCER RESEARCH (2005)
Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines
ML Salem
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
RA Siddiqui et al.
BREAST CANCER RESEARCH (2005)
Effect of propofol and isoflurane anaesthesia on the immune response to surgery
T Inada et al.
ANAESTHESIA (2004)
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer
K Krysan et al.
CANCER RESEARCH (2004)
Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation
A Pozzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A pathway through interferon-γ is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells
M Matsuura et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma
C Denkert et al.
CANCER (2003)
Increased surgical stress promotes tumor metastasis
Y Tsuchiya et al.
SURGERY (2003)
Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: Mediating mechanisms and prophylactic measures
R Melamed et al.
ANESTHESIA AND ANALGESIA (2003)
Intravenous anesthetic, propofol inhibits invasion of cancer cells
T Mammoto et al.
CANCER LETTERS (2002)
Induction and mechanism of apoptotic cell death by propofol in HL-60 cells
M Tsuchiya et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2002)
Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients
K Furukawa et al.
NUTRITION (2002)
Cyclooxygenase-2-issued prostaglandin E-2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions
H Harizi et al.
JOURNAL OF IMMUNOLOGY (2002)
Fatty fish consumption and risk of prostate cancer
P Terry et al.
LANCET (2001)
Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection
K Yamaguchi et al.
ANNALS OF SURGERY (2000)
Share Paper
